chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received three sets of the HPV vaccination via recommendation. Approximately a month or so after receiving the first vaccination, the first incident/possible reaction occurred. The first reaction was the temporary paralysis/numbness of my right arm. The numbness happened instantly without my knowing it. I realized it was numb when I moved my arm and scared myself because I did not feel my arm move towards my face. Other symptoms during this incident included feeling weary and lightheaded to the point where I needed to rest for a few moments. The incident lasted for approximately 10 minutes and was over after I sat down and drank water. The second, last, and most severe incident occurred a few weeks after the first incident. The second incident occurred while I was looking at a computer screen and my right fingertips started to become numb. The numbness lasted over maybe 10 minutes and over time, the numbness went from my fingertips up my right arm/shoulder and down my right thigh and leg. Along with the temporary paralysis of the right side of my body, I had blurred vision in both eyes, lightheadedness, felt overheated,  and had to lay down because I did not feel stable enough sitting up. After my vision came back to me normal and I felt a little bit better, I was driven to the local hospital where I was "officially" diagnosed with migraines and given 3 different medications that would help my symptoms. Prior to the HPV shot, I had migraines and headache often but never did I have the symptoms or similar symptoms close to what I had after receiving the HPV shot. After receiving the second and third dose of the HPV shot series and to this day I have not experienced those symptoms except the temporary numbness in my right fingertips or forearm (this may or may not be from the shot) which comes here and there but nothing stresfful or frequent. The doctor who treated me at the local hospital said from a personal and non-official opinion that he believed the reaction and symptoms were from the HPV shot, not migraines, but from a medical professional stand, he could not state that opinion.
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with 0.65mL of zoster vaccine live (Oka/Merck). Subsequently, the patient experienced "joint inflammation." Unspecified medical attention was sought. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Mild pain at the injection site the next day; Mild headache within 1-2 hours of injection; Mild headache within 1-2 hours of injection; This is a spontaneous report received from a contactable physician (who is also the patient). A 56-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH 9899), via an unspecified route of administration in left arm on 18Dec2020 13:15 at single dose for COVID-19 immunization. Medical history included history of headaches and dyslipidemia. The patient has no known allergies. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced mild headache within 1-2 hours of injection on 18Dec2020 and mild pain at the injection site the next day on 19Dec2020. The patient did not receive treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events in Dec2020 (reported as "resolved within 24-48 hours"). The reporter assessed the report as non-serious.
Next day swelling, redness, approx. 3" around site. Pt reports pain/loss of movement 1 week after to currently. Pt has not seen a doctor.
Fever, chills, severe headache, muscle aches, leg nerve sensitivity (tingling), fatigue
FLUBLOK given to a 17-year-old with no reported adverse event; Initial information received on 25-Oct-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves, influenza quadrivalent recombinant vaccine [Flublok qiv] given to a 17-year-old (male) with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.  On 25-Oct-2023, the patient received 0.5 ml total dose of suspect influenza quadrivalent recombinant vaccine (strength, form: unknown) (lot: QFAA2332, expiry date: 30-Jun-2024) via intramuscular route in the deltoid Nos for Immunization and flublok given to a 17-year-old with no reported adverse event (product administered to patient of inappropriate age) (latency: same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient got vaccinated with the flu vaccine on 9/9/19. She states that her right arm where she got the shot has been very painful ever since.
Fever 101, diarrhea, nausea started 4/29/2021. Arm pain with swelling up to her neck with some lymph node enlargement in her neck area.
This spontaneous report as received from a physician, who is patient's son also refers to a 85 year old male patient. There was no pertinent medical history reported. No drug reaction or allergy was reported. On 30-DEC-2013 the patient was vaccinated with ZOSTAVAX (lot number and dose not reported). Concomitant therapies included CADUET. In January 2014 (reported as approximately 2-4 weeks after receiving ZOSTAVAX), the patient experienced acute exacerbation of Alzheimer's disease (hospitalization, disability and life threatening) and mental status changes (hospitalization, disability and life threatening). The patient sought medical attention for the events. Treatment was not given for the events. The patient was hospitalized for 5 days. The outcome of events was reported as not recovered. The causality of the suspect product with the event was not reported. Product quality complaint was not reported. Additional information has been requested.
Patient experience a sore arm following the vaccination that has not improved since the vaccination. Patient sought medical treatment and received a steroid shot. Patient stated that MD examining arm stated that the deltoid muscle in the arm was collapsed and would take time to recover. Patient is continuing to seek medical care and will follow up with the pharmacy if there are any new developments in health status. Patient experienced no issues with the 1st dose of the shingrix vaccine
Febrile to 40.1 in ED following febrile seizures at home.
It began as severe chest pain, principally in the left side and in the center, radiating to the neck, shoulder, and back. Extremely severe in the back. It was a very stabbing type of pain. It was quite severe. It started at about 9 PM. My son transported me to the hospital at about 11:45PM. My concern was that I was having a heart attack. I was in the ER until early morning. They treated it with a nitroglycerine paste, started a heparin drip, several morphine injections, which were ineffective. I had a CT scan, echocardiogram, 3 EKGs, chest x-ray, this is all subsequent to having a heart attack last April. The pain for this incident was actually worse than the heart attack on April. The medical tests indicated I did not have a heart attack. After leaving the hospital at noon, I had discomfort in the chest. When I breathe, I feel like my lungs are quite constricted and I do not get enough air. But it is getting better each day. I think I had pericarditis. My son who is a pulmonary physician also thinks the same thing, but the ER did not give me any diagnosis.
104.0 Temp on 5/18/2017 approx 8 hours post vaccine.
This spontaneous report was received from a researcher refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 08-MAR-2019 the patient was vaccinated with improperly stored ROTATEQ lot # R016790 (expiry date: 20-APR-2020), orally for prophylaxis. It was stated that the vaccine underwent a temperature excursion of -1.8 degree celsius for 33 minutes; Previous temperature excursion included 11.3 degree celsius for 30 minutes. The call was because of a "data logger". Dose administered after initial warm excursion. No adverse effects reported.
sudden drop of blood pressure, blurry vision and dizziness. Fever, body aches and pain in the injection site for 3 days.
Felt tired at 3:20PM, laid down to nap, woke up at 6:07, got up to use the restroom, blacked out on my way back to bed. Dizziness lasted couple hours. Extremely lethargic. Was only awake for a few hours that night, slept until next morning at 7:24AM.
Fatigue, decreased sense of taste and smell, headache, rhinitis, sore thoraot, cough, dyspnea, diarrhea, nausea, vomiting, myalgia, blurry vision since 2nd Moderna dose, not tested for COVID, was sent to ER when presented to office w/ symptoms and orthostatic hypotension.
Severe inflammation in shoulder. Patient believes its bursitis. Personal physician diagnosed as inflammation of shoulder as a result of vaccine.
headache and burning inside the head; headache and burning inside the head; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache and burning inside the head) and BURNING SENSATION (headache and burning inside the head) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache and burning inside the head) and BURNING SENSATION (headache and burning inside the head). At the time of the report, HEADACHE (headache and burning inside the head) and BURNING SENSATION (headache and burning inside the head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Patient had extreme pain in upper (R) arm. Shot was given (pneumococcal vaccine) about 1515 on 10/3/2011. Pt taken to ED at 2216 - 10/3/2011.
ON 4/21/06 CLIENT CALLED TO REPORT THAT YESTERDAY HER LEFT ARM BECAME SORE AND SWOLLEN. ALSO HAS TEMPERATURE OF 102 DEGREES. STATES IT IS DIFFICULT TO LIFT HER ARM.
redness @ site 4cm & tingling in arm immed following inj;disappeared p/15mins;
Information has been received from a 73 year old male who on 22-APR-2008 was vaccinated with zoster vaccine live (Oka/Merck) 0.65 ml subcutaneous (SC) (Lot # not provided). Concomitant therapy included montelukast sodium (MSD), tiotropium bromide (SPIRIVA), hydrochlorothiazide (HYDREX (hydrochlorothiazide)), atenolol (TONOCOR (atenolol), potassium (unspecified), fexofenadine hydrochloride (ALLEGRA) and ranitidine HCL (ZANTAC). On that same day, the patient developed red face and eyes, red spots on body and arms, bottom of feet burning and peeling, difficulty breathing, cold like symptoms, coughing, and sensitivity to sunlight. At the time of this report, the patient was recovering from the events. Unspecified medical information was sought.
Lost power the next day in the middle of the day at 12:00 PM.; No adverse event; Vaccine went tempearture excursion and was adminstered between 02-MAR-2023 to 28-MAR-2023.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Lost power the next day in the middle of the day at 12:00 PM.), POOR QUALITY PRODUCT ADMINISTERED (Vaccine went tempearture excursion and was adminstered between 02-MAR-2023 to 28-MAR-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 066H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    In March 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In March 2023, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine went tempearture excursion and was adminstered between 02-MAR-2023 to 28-MAR-2023.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Lost power the next day in the middle of the day at 12:00 PM.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Lost power the next day in the middle of the day at 12:00 PM.), POOR QUALITY PRODUCT ADMINISTERED (Vaccine went tempearture excursion and was adminstered between 02-MAR-2023 to 28-MAR-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Lost power the next day in the middle of the day at 12:00 PM.) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine went tempearture excursion and was adminstered between 02-MAR-2023 to 28-MAR-2023.).    It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No concomitant medications were reported.  Temperature excursion occurred due to lost power in the middle of the day at 12:00 PM. Had placed all vaccine into a frozen bag. Booster vaccines were then transported to another clinic. On 02-Mar-2023 to 28-Mar-2023, vaccines were administered to 26 Patients at facility. No reported symptoms.  No treatment medications was reported.  This case was reported for Patient 20 out of 26 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-718370 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718370:(Patient 1)
Swelling of right eyelid 10/7/12, swelling continued through 10/8/12, antibiotics administered to no relief, admitted to hospital 10/09/2012 diagnosed with periorbital cellulited, I&D right eyelid performed 10/10/2012.
Flu-like symptoms, Diarrhea, Stomach pain, fatigue, Headache muscle pain. Treated with TYLENOL (not able to take Ibuprofen because of Blood Thinner). Somewhat debilitating. Bed rest. Immediate sharp pain in arm, then redness, swelling, extreme tenderness still 3 days later. Could not even touch the arm. I talked to Pharmacy that gave shot. No advice about flu symptoms except TYLENOL. Recommended BENADRYL cream to area where shot was given. Not super helpful or concerned. I also had a strong reaction to the first SHINGRIX vaccine, but not nearly as strong as this. First does was given at Dr's office, but Doctor, somehow could not get a supply of vaccine for the 2nd shot, so I was referred to my pharmacy.
Pt was hospitalized for SOB. Found to have acute hypoxic respiratory failure in setting of confirmed rhinovirus infection, as well as NSTEMI. Pt had cardiac echo showing new ejection fraction depression to 40%, and subsequently underwent cardiac catheterization with clean coronaries. Differential diagnosis at this time is viral induced myocarditis vs vaccine induced myocarditis.
Patient collapsed in home and was non responsive. Could not speak or stand up. 911 was called and patient taken to emergency room.  Spent one night in the hospital.
2wk p/vax had chicken pox, fever-low, flu sx-achy, several pox-all over body-not counted-not as many pox as usual-i.e.: other children @ other episodes;twin did not get chicken pox;
Information has been received from a physician's assistant concerning a 13 year old female patient who on 08-NOV-2008 was vaccinated with the first 0.5ml dose of GARDASIL (lot # not reported). On 17-FEB-2010 the patient was vaccinated with the second 0.5ml dose of GARDASIL (lot # not reported). On 18-FEB-2010 the patient  developed swelling around the eyes after the second vaccination. It was reported that the patient didn't experience any adverse events after the first vaccination. Unspecified medical attention was sought. At the time of this report, the patient had not recovered. Additional information has been requested.
bacterial infection (ecoli); bacterial infection (ecoli), not a viral infection and became septic; organ shutdown/gall bladder removed; This case was reported by a pharmacist via call center representative and described the occurrence of escherichia coli infection in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd July 2019, the patient received the 1st dose of Shingrix. On an unknown date, 2 months after receiving Shingrix, the patient experienced escherichia coli infection (serious criteria hospitalization and GSK medically significant), septicemia due to escherichia coli (e. coli) (serious criteria hospitalization and GSK medically significant) and organ failure (serious criteria hospitalization). The patient was treated with prednisone. On an unknown date, the outcome of the escherichia coli infection, septicemia due to escherichia coli (e. coli) and organ failure were recovered/resolved.   It was unknown if the reporter considered the escherichia coli infection, septicemia due to escherichia coli (e. coli) and organ failure to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the 1st dose of Shingrix and two months after receiving the dose, the patient had a viral infection (pharmacist did not know what virus), organ shutdown and was hospitalized for 2 months.  The patient recovered but he has been taking Prednisone since, 9 mg daily. The patient has not received the 2nd dose of Shingrix till the time of reporting. Upon follow up it was stated that the patient had a bacterial infection (ecoli), not a viral infection and patient became septic. The patient underwent gall bladder removal.
This spontaneous report as received from a healthcare worker/office manager via a company representative refers to a patient of unknown age and gender. Healthcare worker reported that the patients had received the first three doses of GARDASIL on a schedule that was outside of the prescribing information and also a fourth dose of GARDASIL (strength, dose, route and lot # unspecified). Patient was administered doses on 24-APR-2012, 08-AUG-2013, 12-AUG-2014 and 13-OCT-2014. No adverse events were reported. The outcome of event was unknown. This is one of several reports received from the same source. Additional information has been requested.
Chills; she threw up; shaking; feel very bad; little cold like she may have a fever; little cold like she may have a fever; This is a spontaneous report from a contactable consumer reported for his wife. A 70-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: unknown), via an intramuscular route of administration in left arm on 27Jan2021 at 15:00 (at the age of 70-years-old), as single dose for covid-19 immunisation. No additional Vaccines administered on the Same date of the Pfizer Suspect. No Prior Vaccinations within 4 weeks of the vaccination was received by the patient. No adverse events following prior vaccinations reported. The patient had no medical history, and no concomitant medications were received. The patient had no history of all previous immunization with the Pfizer vaccine considered as suspect. On 29Jan2021, 2 days after receiving the vaccine, the patient experienced chills, threw up, shaking, started to feel very bad and hadlittle cold and fever. It was reported that she felt fine the day of getting the vaccine and yesterday and about 2 hours ago today, she had bad chills and threw up. She felt better once she threw up. She still feels a little cold like she may have a fever, but the shaking is over. The patient did not visit emergency room and physician Office. No relevant rests were conducted. The event shaking was resolved on an unspecified date in 2021. The outcome of the event threw up was resolving. The outcome of the other events was not reported. The reporter wants to know if these side effects are still associated with the vaccine. No investigation assessment was provided.   Information about Batch/Lot number has been requested   Follow-up attempts are completed. No further information is expected.
Hives, erythema, warmth/redness at site of injection. Muscle soreness on entire arm.
pain very badly; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain very badly) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN (pain very badly). At the time of the report, PAIN (pain very badly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.
Information was received on 12-SEP-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. It was reported that the patient was vaccinated with a dose of ZOSTAVAX (lot number, dosage, and route of administration not provided) on or about 17-OCT-2013 at a physicians office as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 08-JUN-2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as shingles. The patient was prescribed valacyclovir for management of her painful and persistent symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
Tired, really sore injection site (that started upon injection), next day both tired and injection soreness. plus muscle aches, general fatigue, onset about 2 hours after injection lasted about 36 hours